NCT05958459 is a NA clinical trial of Eye Exercise in Cataract, sponsored by Idrıs Dogan.

Who is sponsoring NCT05958459?

NCT05958459 is sponsored by Idrıs Dogan.

What drugs are being tested in NCT05958459?

Interventions in NCT05958459: Eye Exercise, no intervention.

What condition does NCT05958459 study?

NCT05958459 studies Cataract, Intraocular Lenses.

Is NCT05958459 still recruiting?

NCT05958459 is currently status unknown. Last updated 24 July 2023.

Last reviewed 2023-07-24 · How we verify

NCT05958459

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Eye Exercises on Visual Function and Quality of Life After Multifocal Intraocular Lens Implantation

Status unknown NA Last updated 24 July 2023

What this trial tests

NA trial testing Eye Exercise in Cataract in 60 participants. Status unknown.

Timeline

4 August 2023

Primary endpoint
25 December 2023

1 January 2024

Quick facts

Lead sponsor	Idrıs Dogan
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	60
Start date	4 August 2023
Primary completion	25 December 2023
Estimated completion	1 January 2024

Drugs / interventions tested

Eye Exercise
no intervention

Conditions studied

Cataract — all drugs for Cataract →
Intraocular Lenses — all drugs for Intraocular Lenses →

Sponsor

Idrıs Dogan

Who can join

40 and older, any sex, with Cataract or Intraocular Lenses. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to examine the effects of eye exercises on visual function and quality of life in cataract patients undergoing multifocal intraocular lens implantation. The main questions it aims to answer are: * Does it improve visual functions? * Does it improve vision-related quality of life? Participants in the intervention group will perform 8-step eye exercises at least once a day for 12 weeks. The control group will not practice, they will only be evaluated.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cataract

Currently open trials in the same condition.

NCT07301385 — Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety a · NA · recruiting
NCT07462000 — Aqueous Humor and Ocular Tissue Analysis in Glaucoma and Cataract · NA · recruiting
NCT06891092 — Vivinex Impress XY1-EM vs RayOne EMV · NA · recruiting
NCT07218796 — Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compar · Phase 3 · recruiting
NCT07218783 — Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compar · Phase 3 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05958459 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Idrıs Dogan
Last refreshed: 24 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05958459.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing